Pathogenic soluble aggregates have been identified with tau pathology from the human brain [38,39], suggesting that seeding overt pathology by soluble aggregates/oligomers may be a general feature of α-synucleinopathy and tauopathy. The gene discussed is MAPT; the disease is synucleinopathy.